NCT06104774 The Effects of a Family-Centered Tai Chi Exercise on Lung Function and Mental Health of Patients After Thoracoscopic Surgery
| NCT ID | NCT06104774 |
| Status | Recruiting |
| Phase | — |
| Sponsor | China Medical University Hospital |
| Condition | Thoracic Neoplasms |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-10-20 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2023-10-20 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To explore the effect of a family-centered, eight-week, progressive sit-to-stand Tai Chi exercise on lung function and mental health in patients after thoracoscopic surgery\_
Eligibility Criteria
Inclusion Criteria: 1. Hospitalized to receive thoracoscopic lobectomy, wedge/partial resection, lobectomy, or sleeve resection. 2. American Society of Anesthesiologists (ASA) physiological status classification I-II (ASA, 2019).ASA Physical Status Class I: A healthy person who is healthy and does not smoke or drink.ASA physical status class II: People with mild chronic diseases but no substantial functional limitations. 3. Those who can walk on their own without any impairment in limb movement. 4. Able to communicate in Chinese or Taiwanese. Exclusion Criteria: 1. Individuals requiring chemotherapy and radiation therapy for malignant tumors. 2. Those who have practiced Tai Chi, Qigong, external elixir exercises, or pulmonary exercises within the past year. 3. Anticipating hospitalization or surgical treatment within the next three months. 4. Individuals with musculoskeletal or peripheral vascular diseases. 5. Individuals with visual impairment, intellectual disabilities, or memory loss.
Contact & Investigator
Hsing-Chi Hsu, Ph.D
PRINCIPAL INVESTIGATOR
HungKuang University, Taiwan
Frequently Asked Questions
Who can join the NCT06104774 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Thoracic Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06104774 currently recruiting?
Yes, NCT06104774 is actively recruiting participants. Contact the research team at fanghy@cmuh.org.tw for enrollment information.
Where is the NCT06104774 trial being conducted?
This trial is being conducted at Taichung, Taiwan.
Who is sponsoring the NCT06104774 clinical trial?
NCT06104774 is sponsored by China Medical University Hospital. The principal investigator is Hsing-Chi Hsu, Ph.D at HungKuang University, Taiwan. The trial plans to enroll 200 participants.